Pesticide Experimental Use Permit; Receipt of Application; Comment Request (93167-EUP-E), 47947 [2019-19665]
Download as PDF
Federal Register / Vol. 84, No. 176 / Wednesday, September 11, 2019 / Notices
Dated: September 4, 2019.
Gautam Srinivasan,
Acting Associate General Counsel.
dockets generally, is available at https://
www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
Robert McNally, Biopesticides and
Pollution Prevention Division (7511P),
Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC
20460–0001; main telephone number:
(703) 305–7090; email address:
BPPDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2019–19668 Filed 9–10–19; 8:45 am]
I. General Information
BILLING CODE 6560–50–P
A. Does this action apply to me?
This action is directed to the public
in general. Although this action may be
of particular interest to those persons
who conduct or sponsor research on
pesticides, the Agency has not
attempted to describe all the specific
entities that may be affected by this
action.
system is not an ‘‘anonymous access’’
system. If you send an email comment
directly to the Docket without going
through www.regulations.gov, your
email address is automatically captured
and included as part of the comment
that is placed in the official public
docket, and made available in EPA’s
electronic public docket.
ENVIRONMENTAL PROTECTION
AGENCY
[EPA–HQ–OPP–2019–0274; FRL–9998–73]
Pesticide Experimental Use Permit;
Receipt of Application; Comment
Request (93167–EUP–E)
Environmental Protection
Agency (EPA).
ACTION: Notice.
AGENCY:
This notice announces EPA’s
receipt of an application from Oxitec,
Ltd. requesting an experimental use
permit (EUP) for the OX5034 Aedes
aegypti mosquitoes expressing
tetracycline Trans-Activator Variant
(tTAV–OX5034) protein (identified by
number 93167–EUP–E). The Agency has
determined that the permit may be of
regional and national significance.
Therefore, because of the potential
significance, EPA is seeking comments
on this application.
DATES: Comments must be received on
or before October 11, 2019.
ADDRESSES: Submit your comments,
identified by docket identification (ID)
number EPA–HQ–OPP–2019–0274, by
one of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Do not submit electronically any
information you consider to be
Confidential Business Information (CBI)
or other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.
NW, Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
follow the instructions at https://
www.epa.gov/dockets/contacts.html.
Additional instructions on
commenting or visiting the docket,
along with more information about
jspears on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:44 Sep 10, 2019
Jkt 247001
B. What should I consider as I prepare
my comments for EPA?
1. Submitting CBI. Do not submit this
information to EPA through
regulations.gov or email. Clearly mark
the part or all of the information that
you claim to be CBI. For CBI
information in a disk or CD–ROM that
you mail to EPA, mark the outside of the
disk or CD–ROM as CBI and then
identify electronically within the disk or
CD–ROM the specific information that
is claimed as CBI. In addition to one
complete version of the comment that
includes information claimed as CBI, a
copy of the comment that does not
contain the information claimed as CBI
must be submitted for inclusion in the
public docket. Information so marked
will not be disclosed except in
accordance with procedures set forth in
40 CFR part 2.
2. Tips for preparing your comments.
When preparing and submitting your
comments, see the commenting tips at
https://www.epa.gov/dockets/
comments.html.
3. Environmental justice. EPA seeks to
achieve environmental justice, the fair
treatment and meaningful involvement
of any group, including minority and/or
low income populations, in the
development, implementation, and
enforcement of environmental laws,
regulations, and policies. To help
address potential environmental justice
issues, the Agency seeks information on
any groups or segments of the
population who, as a result of their
location, cultural practices, or other
factors, may have atypical or
disproportionately high and adverse
human health impacts or environmental
effects from exposure to the pesticide(s)
PO 00000
Frm 00017
Fmt 4703
Sfmt 9990
47947
discussed in this document, compared
to the general population.
II. What action is the agency taking?
Under section 5 of the Federal
Insecticide, Fungicide and Rodenticide
Act (FIFRA), 7 U.S.C. 136c, EPA can
allow manufacturers to field test
pesticides under development.
Manufacturers are required to obtain an
EUP before testing new pesticides or
new uses of pesticides if they conduct
experimental field tests on 10 acres or
more of land or one acre or more of
water.
Pursuant to 40 CFR 172.11(a), the
Agency has determined that the
following EUP application may be of
regional and national significance, and
therefore is seeking public comment on
the EUP application:
Submitter: Oxitec, Ltd., (93167–EUP–
E).
Pesticide Chemical: OX5034 Aedes
aegypti mosquitoes expressing
tetracycline Trans-Activator Variant
(tTAV–OX5034) protein.
Summary of Request: Oxitec Ltd. is
proposing to test OX5034 Aedes aegypti
mosquitoes expressing tTAV–OX5034
protein in the states of Florida and
Texas on up to 6600 total acres at a
maximum rate of 0.000056 g active
ingredient (tTAV–OX5034), equivalent
to 20,000 male OX5034 mosquitoes, per
acre per week. The proposed
experiments are to evaluate the efficacy
of OX5034 mosquitoes as a tool for
suppression of wild Aedes aegypti
mosquito populations. Female offspring
of the OX5034 mosquitoes in the
environment are expected to die before
they mature into adults and therefore
exposure to biting female mosquitoes is
not anticipated.
Following the review of the
application and any comments and data
received in response to this solicitation,
EPA will decide whether to issue or
deny the EUP request, and if issued, the
conditions under which it is to be
conducted. Any issuance of an EUP will
be announced in the Federal Register.
Authority: 7 U.S.C. 136 et seq.
Dated: September 5, 2019.
Alexandra Dapolito Dunn,
Assistant Administrator, Office of Chemical
Safety and Pollution Prevention.
[FR Doc. 2019–19665 Filed 9–10–19; 8:45 am]
BILLING CODE 6560–50–P
E:\FR\FM\11SEN1.SGM
11SEN1
Agencies
[Federal Register Volume 84, Number 176 (Wednesday, September 11, 2019)]
[Notices]
[Page 47947]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19665]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[EPA-HQ-OPP-2019-0274; FRL-9998-73]
Pesticide Experimental Use Permit; Receipt of Application;
Comment Request (93167-EUP-E)
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces EPA's receipt of an application from
Oxitec, Ltd. requesting an experimental use permit (EUP) for the OX5034
Aedes aegypti mosquitoes expressing tetracycline Trans-Activator
Variant (tTAV-OX5034) protein (identified by number 93167-EUP-E). The
Agency has determined that the permit may be of regional and national
significance. Therefore, because of the potential significance, EPA is
seeking comments on this application.
DATES: Comments must be received on or before October 11, 2019.
ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2019-0274, by one of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be Confidential Business
Information (CBI) or other information whose disclosure is restricted
by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW, Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/contacts.html.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: Robert McNally, Biopesticides and
Pollution Prevention Division (7511P), Office of Pesticide Programs,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington,
DC 20460-0001; main telephone number: (703) 305-7090; email address:
[email protected].
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
This action is directed to the public in general. Although this
action may be of particular interest to those persons who conduct or
sponsor research on pesticides, the Agency has not attempted to
describe all the specific entities that may be affected by this action.
B. What should I consider as I prepare my comments for EPA?
1. Submitting CBI. Do not submit this information to EPA through
regulations.gov or email. Clearly mark the part or all of the
information that you claim to be CBI. For CBI information in a disk or
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as
CBI and then identify electronically within the disk or CD-ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
2. Tips for preparing your comments. When preparing and submitting
your comments, see the commenting tips at https://www.epa.gov/dockets/comments.html.
3. Environmental justice. EPA seeks to achieve environmental
justice, the fair treatment and meaningful involvement of any group,
including minority and/or low income populations, in the development,
implementation, and enforcement of environmental laws, regulations, and
policies. To help address potential environmental justice issues, the
Agency seeks information on any groups or segments of the population
who, as a result of their location, cultural practices, or other
factors, may have atypical or disproportionately high and adverse human
health impacts or environmental effects from exposure to the
pesticide(s) discussed in this document, compared to the general
population.
II. What action is the agency taking?
Under section 5 of the Federal Insecticide, Fungicide and
Rodenticide Act (FIFRA), 7 U.S.C. 136c, EPA can allow manufacturers to
field test pesticides under development. Manufacturers are required to
obtain an EUP before testing new pesticides or new uses of pesticides
if they conduct experimental field tests on 10 acres or more of land or
one acre or more of water.
Pursuant to 40 CFR 172.11(a), the Agency has determined that the
following EUP application may be of regional and national significance,
and therefore is seeking public comment on the EUP application:
Submitter: Oxitec, Ltd., (93167-EUP-E).
Pesticide Chemical: OX5034 Aedes aegypti mosquitoes expressing
tetracycline Trans-Activator Variant (tTAV-OX5034) protein.
Summary of Request: Oxitec Ltd. is proposing to test OX5034 Aedes
aegypti mosquitoes expressing tTAV-OX5034 protein in the states of
Florida and Texas on up to 6600 total acres at a maximum rate of
0.000056 g active ingredient (tTAV-OX5034), equivalent to 20,000 male
OX5034 mosquitoes, per acre per week. The proposed experiments are to
evaluate the efficacy of OX5034 mosquitoes as a tool for suppression of
wild Aedes aegypti mosquito populations. Female offspring of the OX5034
mosquitoes in the environment are expected to die before they mature
into adults and therefore exposure to biting female mosquitoes is not
anticipated.
Following the review of the application and any comments and data
received in response to this solicitation, EPA will decide whether to
issue or deny the EUP request, and if issued, the conditions under
which it is to be conducted. Any issuance of an EUP will be announced
in the Federal Register.
Authority: 7 U.S.C. 136 et seq.
Dated: September 5, 2019.
Alexandra Dapolito Dunn,
Assistant Administrator, Office of Chemical Safety and Pollution
Prevention.
[FR Doc. 2019-19665 Filed 9-10-19; 8:45 am]
BILLING CODE 6560-50-P